NASDAQ
Capricor Therapeutics, Inc. (CAPR) reported revenue of $0 and net income of $-105,043,946 for FY 2025, with a net profit margin of 0%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.